Vanberra Signal

ArisGlobal

Curated by Signal

Platform providing drug development solutions using cognitive computing

Overview

ArisGlobal provides a cloud-based platform for helping the healthcare industry in the drug development process. Uses its proprietary Nava cognitive computing engine and provides automation in the development process, integrates document management solution across the product lifecycle and provides drug safety solutions. Practice areas include pharmacovigilance and safety, regulatory affairs, clinical research (clinical trial management, electronic data capture & supply chain management) and medical communications. Clients include AstraZeneca, Teva, Roche and more.

Key facts

Founded
1986

Business model

Contact

Open roles

16 roles
  • Principal Data Architect

    United Kingdom · On-site · Volunteer

  • Software Engineering Director

    Zagreb, Croatia · On-site · Volunteer

  • Quality Engineer

    Zagreb, Croatia · On-site · Volunteer

+ 13 more open roles on Signal

More on Vanberra Signal

Members only
  • Platform that offers AI driven solutions for organizations

    Enterprise Software & InfrastructureCincinnati, United States
  • Provider of employee wellness and administration platform

    Enterprise Software & InfrastructureCharleston, United States
  • Platform offering data driven decision support software

    Enterprise Software & InfrastructureHauppauge, United States

About ArisGlobal

What does ArisGlobal do?

ArisGlobal provides a cloud-based platform for helping the healthcare industry in the drug development process.

Where is ArisGlobal headquartered?

ArisGlobal is headquartered in Princeton, United States.

When was ArisGlobal founded?

ArisGlobal was founded in 1986.

Which sector is ArisGlobal in?

ArisGlobal operates in Enterprise Software & Infrastructure.

Who are ArisGlobal's competitors?

Companies similar to ArisGlobal include Qualz.ai, 843 Benefits, and RYAILITI.

Is ArisGlobal hiring?

Yes. ArisGlobal has 16 open roles listed on Vanberra Signal.